Kewaunee Scientific Corporation
KEQU
$34.15
-$0.12-0.35%
NASDAQ
| 01/31/2026 | 10/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.99% | -1.42% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.99% | -1.42% | |||
| Cost of Revenue | 0.95% | 0.40% | |||
| Gross Profit | -5.96% | -5.78% | |||
| SG&A Expenses | 2.24% | -3.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.25% | -0.46% | |||
| Operating Income | -37.13% | -14.62% | |||
| Income Before Tax | -53.55% | -11.91% | |||
| Income Tax Expenses | -42.30% | 20.24% | |||
| Earnings from Continuing Operations | -57.60% | -19.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -312.90% | -40.91% | |||
| Net Income | -71.70% | -20.95% | |||
| EBIT | -37.13% | -14.62% | |||
| EBITDA | -26.52% | -10.57% | |||
| EPS Basic | -71.69% | -21.37% | |||
| Normalized Basic EPS | -70.05% | -13.82% | |||
| EPS Diluted | -71.95% | -21.15% | |||
| Normalized Diluted EPS | -69.99% | -14.16% | |||
| Average Basic Shares Outstanding | 0.00% | 0.53% | |||
| Average Diluted Shares Outstanding | -0.23% | 0.91% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||